Quantcast

Latest Galeterone Stories

2014-06-03 12:39:42

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:The Prostate Cancer Therapeutics Market 2013-2023http://www.reportbuyer.com/pharma_healthcare/treatments/prostate_cancer_therapeutics_market_2013_2023.html Report DetailsProstate cancer therapeutics - assess products, developments, and revenue prospectsHow are the leading segments in the prostate cancer therapeutics market performing? Visiongain's new report shows you their prospects to 2023....

2014-06-02 08:30:44

Phase 2 study data presented at the 50th annual meeting of the American Society of Clinical Oncology HORSHAM, Pa., June 2, 2014 /PRNewswire/ -- Abiraterone acetate (ZYTIGA(®)) plus prednisone demonstrated statistically significant reductions in PSA levels at six months, the primary endpoint of the IMAAGEN trial, which evaluates the investigational use of abiraterone acetate plus prednisone (5 mg once daily) in patients with non-metastatic castration-resistant prostate cancer...

2014-03-27 08:33:33

DUBLIN, Mar. 27, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/djkgl4/therapeutic_class ) has announced the addition of the "Therapeutic Class Overview: Newer Oral Anti Androgens - Expanding Role in the Treatment Paradigm of Prostate Cancer" report to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769) In recent past approval and launch of various newer treatment options like Xtandi (Enzalutamide,...

2014-02-24 12:26:47

DALLAS, February 24, 2014 /PRNewswire/ -- ReportsnReports.com offers "Therapeutic Class Overview : Emergence Of Biogenerics Era In Japan - It's Time to Welcome Antibody Biosimilars of Foreign Origins Soon" and "Therapeutic Class Overview: Newer Oral Anti Androgens - Expanding Role in the treatment Paradigm of Prostate Cancer" research reports in its store. Japan biosimilar market will enter new phase of biosimilars with first 'mab' approval expected in 2014. This...

2013-11-12 23:27:36

Reportbuyer.com just published a new market research report: The Prostate Cancer Therapeutics Market 2013-2023. London (PRWEB) November 12, 2013 Report Details Prostate cancer therapeutics - assess products, developments, and revenue prospects How are the leading segments in the prostate cancer therapeutics market performing? Visiongain's new report shows you their prospects to 2023. There you see results, trends, opportunities, and revenue predictions. Our study lets you assess...


Word of the Day
grass-comber
  • A landsman who is making his first voyage at sea; a novice who enters naval service from rural life.
According to the OED, a grass-comber is also 'a sailor's term for one who has been a farm-labourer.'